05.24.21 -- Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials
This report provides data on 240 service provider encounters with 18 electronic clinical outcome assessment/electronic patient reported outcomes (eCOA/ePRO) systems. eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection process. Explore new providers and understand how they have performed for industry peers.
Clinical Leader
In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb, discuss the guidance issued by regulators to help drug developers that are implementing decentralized trials.